| What is the right dose for children? M Cella, C Knibbe, M Danhof, O Della Pasqua British journal of clinical pharmacology 70 (4), 597, 2010 | 181 | 2010 |
| Prediction of propofol clearance in children from an allometric model developed in rats, children and adults versus a 0.75 fixed-exponent allometric model MYM Peeters, K Allegaert, HJB van Oud-Alblas, M Cella, D Tibboel, ... Clinical pharmacokinetics 49, 269-275, 2010 | 81 | 2010 |
| A model‐based approach to dose selection in early pediatric development M Cella, F Gorter de Vries, D Burger, M Danhof, O Della Pasqua Clinical Pharmacology & Therapeutics 87 (3), 294-302, 2010 | 74 | 2010 |
| Paediatric drug development: are population models predictive of pharmacokinetics across paediatric populations? M Cella, W Zhao, E Jacqz‐Aigrain, D Burger, M Danhof, OD Pasqua British journal of clinical pharmacology 72 (3), 454-464, 2011 | 50 | 2011 |
| Memantine prevents reference and working memory impairment caused by sleep deprivation in both young and aged Octodon degus E Tarragon, D Lopez, C Estrada, A Gonzalez-Cuello, CM Ros, Y Lamberty, ... Neuropharmacology 85, 206-214, 2014 | 36 | 2014 |
| Pharmacogenetics and paediatric drug development: issues and consequences to labelling and dosing recommendations EHJ Krekels, JN Anker, P Baiardi, M Cella, KY Cheng, DM Gibb, H Green, ... Expert Opinion on Pharmacotherapy 8 (12), 1787-1799, 2007 | 27 | 2007 |
| Scaling of pharmacokinetics across paediatric populations: the lack of interpolative power of allometric models M Cella, C Knibbe, SN de Wildt, J Van Gerven, M Danhof, O Della Pasqua British journal of clinical pharmacology 74 (3), 525-535, 2012 | 26 | 2012 |
| Impact of simulated lung fluid components on the solubility of inhaled drugs and predicted in vivo performance S Radivojev, G Luschin-Ebengreuth, JT Pinto, P Laggner, A Cavecchi, ... International Journal of Pharmaceutics 606, 120893, 2021 | 21 | 2021 |
| Adaptive trials in paediatric development: dealing with heterogeneity and uncertainty in pharmacokinetic differences in children M Cella, M Danhof, O Della Pasqua British journal of clinical pharmacology 74 (2), 346-353, 2012 | 21 | 2012 |
| Model‐based assessment of alternative study designs in pediatric trials. Part II: Bayesian approaches G Smania, P Baiardi, A Ceci, M Cella, P Magni CPT: pharmacometrics & systems pharmacology 5 (8), 402-410, 2016 | 12 | 2016 |
| Population pharmacokinetics and maximum a posteriori probability Bayesian estimator of abacavir: application of individualized therapy in HIV‐infected infants and … W Zhao, M Cella, O Della Pasqua, D Burger, E Jacqz‐Aigrain, ... British journal of clinical pharmacology 73 (4), 641-650, 2012 | 12 | 2012 |
| Effects of acute administration of donepezil or memantine on sleep-deprivation-induced spatial memory deficit in young and aged non-human primate grey mouse lemurs (Microcebus … A Rahman, Y Lamberty, E Schenker, M Cella, S Languille, R Bordet, ... Plos one 12 (9), e0184822, 2017 | 11 | 2017 |
| Dosing Rationale for Fixed‐Dose Combinations in Children: Shooting From the Hip? M Cella, F Kloprogge, M Danhof, O Della Pasqua Clinical Pharmacology & Therapeutics 91 (4), 718-725, 2012 | 8 | 2012 |
| Therapeutic drug monitoring strategies for envarsus in de novo kidney transplant patients using population modelling and simulations E Henin, M Govoni, M Cella, C Laveille, G Piotti Advances in Therapy 38, 5317-5332, 2021 | 5 | 2021 |
| Concentration–QT Modeling Following Inhalation of the Novel Inhaled Phosphodiesterase‐4 Inhibitor CHF6001 in Healthy Volunteers Shows an Absence of QT Prolongation K Jolling, A Äbelö, N Luyckx, MA Nandeuil, M Govoni, M Cella, ... CPT: Pharmacometrics & Systems Pharmacology 8 (7), 460-468, 2019 | 5 | 2019 |
| Ethnic sensitivity study of the extrafine, single-inhaler, triple therapy beclomethasone dipropionate, formoterol fumarate, and glycopyrronium bromide pressurized metered dose … M Cella, J Täubel, I Delestre-Levai, A Tulard, A Vele, G Georges Clinical Therapeutics 43 (11), 1934-1947. e4, 2021 | 4 | 2021 |
| Bridging strategies for drug combinations in pediatric indications M Cella, M Danhof, O Della Pasqua CliNiCAl PhARmACOlOGy & TheRAPeUTiCs 91 (4), 726-733, 2012 | 3 | 2012 |
| Population pharmacokinetic modelling of CHF6001 following dry powder inhalation in healthy volunteers K Jolling, M Cella, M Govoni, MA Nandeuil, A Lindauer PAGE Conference, 2018 | 2 | 2018 |
| Model-based comparison of alternative study designs in pediatric trials G Smania, P Baiardi, M Cella, P Magni Part II: Bayesian approaches. CPT Pharmacometrics Syst. Pharmacol.(submitted), 2015 | 1 | 2015 |
| The Bioavailability of CHF6563, an Ethanol-Free, Sublingual Neonatal Buprenorphine Formulation: A Bridging Study Conducted in Adults WK Kraft, I Barneschi, M Bocchi, D Santoro, M Cella The Journal of Pediatric Pharmacology and Therapeutics 29 (1), 49-52, 2024 | | 2024 |
